Junling Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Junling Yang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Bo Liu
Southwest Eye Hospital, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.and Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Southwest Eye Hospital, Southwest Hospital, Chongqing 400038, China
1 shared publicationCao Yang
Southwest Eye Hospital, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.and Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Southwest Eye Hospital, Southwest Hospital, Chongqing 400038, China
1 shared publication- Dayu Sun
Southwest Hospital/Southwest Eye Hospital, Third Military Medical University, Chongqing, 400038, China
1 shared publication - Haiwei Xu
Southwest Eye Hospital, Southwest Hospital, Third Military Medical University (Army Medical University)
1 shared publication Lingling Ge
Southwest Eye Hospital, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.and Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Southwest Eye Hospital, Southwest Hospital, Chongqing 400038, China
1 shared publicationMinghui Li
Southwest Eye Hospital, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, China.and Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Southwest Eye Hospital, Southwest Hospital, Chongqing 400038, China
1 shared publication
Latest Publications
- 8 June 2020
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 12 (25) , 13637-13653
Toxicity and mechanism of mesoporous silica nanoparticles in eyes
It aims to explore the toxicity and mechanism of large-surface-area MSiNPs and MSiNPs-Ag+ exposed to hCEC cells and cornea. A protein corona-based therapy was proposed to treat MSiNPs and MSiNPs-Ag+ induced corneal damage and dry eye.
- 8 June 2020
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 12 (25) , 13637-13653
Toxicity and mechanism of mesoporous silica nanoparticles in eyes
It aims to explore the toxicity and mechanism of large-surface-area MSiNPs and MSiNPs-Ag+ exposed to hCEC cells and cornea. A protein corona-based therapy was proposed to treat MSiNPs and MSiNPs-Ag+ induced corneal damage and dry eye.